The pharma regulator's Subject Expert Committee (SEC) has recommended that Bharat Biotech's Covaxin be approved for emergency use in children aged 2 to 18. The SEC has submitted its proposal for final clearance to the Drugs Controller General of India (DCGI).

COVID-19: Covaxin gets emergency use nod for children aged 2-18 years

child-volunteers

Child Volunteers, News on Child Volunteers, stories on Child Volunteers, articles on Child Volunteers, Child Volunteers stories at Wion, Child Volunteers news, Child Volunteers latest news

child volunteers

COVID-19: Covaxin gets emergency use nod for children aged 2-18 years